Yanyan Zhou advises clients on a broad spectrum of transactions and regulatory matters in the healthcare industry.
Yanyan guides private equity firms, physician practices, life sciences and digital health companies, hospitals, and strategic investors through complex strategic and operational issues involving:
Mergers and acquisitions, strategic affiliations, and joint ventures
Physician practice management
Regulatory approval and consent
Facility and provider licensing and accreditation
State transaction reviews
Changes of ownership
She leverages a commercial approach and deep healthcare regulatory experience to counsel providers on a range of day-to-day issues, including fraud and abuse, self-referral, and government program enrollment and reimbursement compliance.
Before joining Latham, Yanyan was an associate at a leading national law firm.
Experience
Yanyan’s experience includes advising:
Healthcare Companies and Providers
US Renal Care, a provider of dialysis services for patients suffering from end-stage renal disease, on its sale to a private investor group led by Bain Capital Private Equity
Massachusetts General Hospital on a first-of-its-kind proton therapy system restoration
Abu Dhabi Health Services Company (SEHA) on its joint venture with the Mayo Clinic to operate Sheikh Shakhbout Medical City, a UAE-based hospital providing specialty care across a range of clinical practices
The Oncology Institute on its business combination with DFP Healthcare Acquisitions
BlueSprig Pediatrics on acquiring Florida Autism Center, a provider of applied behavior analysis treatment services to children with autism spectrum disorder
Assertio Holdings on acquiring Spectrum Pharmaceuticals
TransUnion on the US$1.7 billion sale of TransUnion Healthcare to nThrive
Investors and Private Equity
Cinven on acquiring National Seating & Mobility, a provider of customized wheelchairs and adaptive seating systems for patients with long-term or permanent loss of mobility
Consonance Capital Partners on its taxable spinoff of Turn-Key Health, a leading community-based palliative care company serving patients in the home, to CareCentrix
KKR on:
Its subsidiary PharMerica’s acquisition of BrightSpring Health Services, a provider of diversified home and community-based health services to complex populations
Investing in Cotiviti
The lenders on AEA Investors’ acquisition of Burke Porter Group
The underwriters on Option Care Health’s offering of 18 million shares of common stock listed on NASDAQ
WestView Capital Partners on its growth investment in PharmaLink
Odyssey on selling Mercalis
SLR Capital on Vapotherm’s merger and take-private
Movendo Capital, as lead investor, on Petfolk’s US$40 million Series B financing
Oak Hill on acquiring American Veterinary Group Holdings
State-level oversight of healthcare M&A, including venture capital, private equity, REIT, and MSO transactions, continues with expanded public disclosure and ongoing reporting obligations.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.
